Edition:
United Kingdom

Takeda Pharmaceutical Co Ltd (4502.T)

4502.T on Tokyo Stock Exchange

4,104JPY
3:29am BST
Change (% chg)

¥-14 (-0.34%)
Prev Close
¥4,118
Open
¥4,081
Day's High
¥4,113
Day's Low
¥4,069
Volume
2,419,400
Avg. Vol
10,287,299
52-wk High
¥4,943
52-wk Low
¥3,498

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -52.67 March 23 Apr 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 4 5 5
(2) OUTPERFORM 9 10 8 8
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.75 1.71 1.62 1.62

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 2 857,594.00 936,887.00 778,300.00 --
Year Ending Mar-19 10 2,333,710.00 3,465,000.00 2,121,900.00 1,783,580.00
Year Ending Mar-20 11 3,462,930.00 3,630,800.00 3,050,000.00 1,848,820.00
Earnings (per share)
Quarter Ending Mar-19 2 -52.67 -21.50 -83.84 --
Year Ending Mar-19 8 141.23 270.15 51.60 192.83
Year Ending Mar-20 8 -13.20 161.94 -103.83 221.02

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-18 488,240.00 499,402.00 11,162.00 2.29
Quarter Ending Jun-18 432,000.00 449,834.00 17,834.00 4.13
Quarter Ending Mar-18 410,578.00 400,963.00 9,615.00 2.34
Quarter Ending Dec-17 447,897.00 488,152.00 40,255.34 8.99
Quarter Ending Sep-17 438,894.00 433,176.00 5,718.00 1.30

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 857,594.00 857,594.00 789,254.00 800,209.00 --
Year Ending Mar-19 2,333,710.00 2,333,710.00 2,337,170.00 2,463,170.00 1,783,580.00
Year Ending Mar-20 3,462,930.00 3,462,930.00 3,492,930.00 3,512,970.00 1,848,820.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-19 0 0 0 0
Year Ending Mar-19 0 0 1 0
Year Ending Mar-20 0 0 1 0
Earnings